
Bristol Myers Squibb: innovating oncology care
Bristol Myers Squibb (BMS), a leading biopharmaceutical company with a dominant position in immuno-oncology, held a press conference in Cyprus on April 29, 2025, where eminent pathologists-oncologists discussed the importance of harnessing ...